Identification of nagilactone E as a protein synthesis inhibitor with anticancer activity.
In conclusion, NLE is a protein synthesis inhibitor with anticancer activity.
PMID: 32047261 [PubMed - as supplied by publisher]
Source: Acta Pharmacologica Sinica - Category: Drugs & Pharmacology Authors: Zhang LL, Guo J, Jiang XM, Chen XP, Wang YT, Li A, Lin LG, Li H, Lu JJ Tags: Acta Pharmacol Sin Source Type: research
More News: Cancer | Cancer & Oncology | Chemistry | Drugs & Pharmacology | Lung Cancer | Molecular Biology | Study